7 completed. 7 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 7 |
| Phase 3 | 2 | Completed 2 |
Follow Dilatation, Pathologic: new trials by email Literature Review of Dilatation, Pathologic trials Research Report on Dilatation, Pathologic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation Tranexamic acid, Placebo - Abortion, Dilation and Evacuation | Phase 2 | Completed | University of Hawaii | 50 | 2022-02-15 | 2026-11-02 |
| Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis Phentolamine Mesylate Ophthalmic Solution 1%, Phentolamine Mesylate Ophthalmic Solution Vehicle (Placebo) - Mydriasis, Dilation | Phase 2 | Completed | Opus Genetics, Inc | 32 | 2019-08-13 | 2026-10-30 |
| Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia Riboflavin, UVX light - Keratoconus, Post-Refractive Ectasia | Phase 2 | Completed | Price Vision Group | 510 | 2010-05-01 | 2018-06-06 |
| Corneal Collagen Cross-Linking for the Treatment of Progressive Keratoconus and Corneal Ectasia Corneal collagen, Sham comparator - Progressive Keratoconus, Corneal Ectasia | Phase 2 / Phase 3 | Completed | Emory University | 160 | 2007-12-01 | 2010-09-02 |
| A Safety Study of AQUAVAN® (Fospropofol Disodium) Injection for Sedation During Minor Surgical Procedures. AQUAVAN® (fospropofol disodium) Injection - Procedural Sedation | Phase 2 / Phase 3 | Completed | Eisai Inc. | 123 | 2006-05-01 | 2012-06-20 |
| Laser Treatment Of Vascular Lesions On Vocal Cords Pulse Dye laser (PDL), CO2 laser or other traditional surgeries - Ectasia | Phase 2 | Completed | Boston University | 7 | 2005-03-01 | 2011-03-31 |
| Phase II Pilot Study of Octreotide, a Somatostatin Octapeptide Analog, for Gastrointestinal Hemorrhage in Hormone-Refractory Hereditary Hemorrhagic Telangiectasia and Senile Ectasia octreotide - Hereditary Hemorrhagic Telangiectasia, Ectasia | Phase 2 | Completed | National Center for Research Resources (NCRR) | 8 | 1995-01-01 | 2005-06-24 |
Keratoconus (2) · Arteriovenous Fistula (1) · Bunion (1) · Corneal Diseases (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemorrhage (1) · Mydriasis (1) · Rare Diseases (1) · Telangiectasia, Hereditary Hemorrhagic (1)
Pathological Conditions, Anatomical (7) · Pathological Conditions, Signs and Symptoms (7) · Eye Diseases (3) · Cardiovascular Abnormalities (2) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Pathologic Processes (2) · Vascular Diseases (2) · Vascular Malformations (2) · Arteriovenous Malformations (1) · Corneal Diseases (1) · Disease Attributes (1) · Fistula (1) · Foot Deformities (1)
Corneal Cross-Linking (1) · Fibrillins (1) · Injections (1) · Lasers, Gas (1) · Octreotide (1) · Riboflavin (1) · Tranexamic Acid (1) · fospropofol (1)
Boston University (1) · Eisai Inc. (1) · Emory University (1) · National Center for Research Resources (NCRR) (1) · Opus Genetics, Inc (1) · Price Vision Group (1) · University of Hawaii (1)
United States (5)
Francis W Price, MD (1) · James B Jones, MD, PharmD (1) · Joshua R. Korzenik (1) · Marit Pearlman Shapiro (1) · R. Doyle Stulting, MD, PhD (1) · Zhi Wang, MD (1)
PMID 25365551, PMID 29203068, PMID 33633016
R21DC006853 (1)